CORE MOLDING TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CORE MOLDING TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2016	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2023	FY2025
Revenue	175	162	269	284	222	307	377	358	302	274
Cost of revenue	147	137	242	263	188	266	325	293	249	226
Gross profit	27.9	24.6	27.1	21.5	34.5	41.3	52.4	64.5	53.3	47.6
Research and development	0.97	0.85	1.03	1.2	1.2	1.3	1.6	1.7	1.9	1.4
Selling, general and administrative	16.4	16.7	27.8	28.9	24.1	30.3	34.4	38	36.6	33.4
Operating expenses			30.2	33	24.1	30.3
Operating income	11.5	7.94	-3.1	-11.5	10.4	11.1	18	26.5	16.7	14.2
Interest expense	0.3	0.25	2.39	4.14	5.92	2.31	1.96	1.01	-0.19	0
Other non-operating income	-0.28	-0.2	2.35	-4.05	-5.84	-2.15	-3.42	-0.79	0.79	0.46
Pre-tax income	11.2	7.75	-5.45	-15.6	4.55	8.92	14.6	25.7	17.5	14.7
Income tax	3.84	2.29	-0.66	-0.36	-3.62	4.25	2.38	5.42	4.18	3.48
Net income	7.41	5.46	-4.78	-15.2	8.17	4.67	12.2	20.3	13.3	11.2
EBITDA	17.8	14.2	6.28	-1.15	22.1	22.7	29.9	39.4	30.1	26.6
EPS, basic	0.97	0.71	-0.62	-1.94	0.98	0.55	1.44	2.37	1.53	1.31
EPS, diluted	0.97	0.70	-0.62	-1.94	0.98	0.55	1.44	2.31	1.51	1.29
Shares, basic (weighted)	7.62	7.69	7.75	7.83	7.94	8.06	8.36	8.55	8.69	8.57
Shares, diluted (weighted)	7.66	7.75	7.75	7.83	7.94	8.06	8.37	8.77	8.79	8.7

Balance sheet

	FY2016	FY2016	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2023	FY2025
Cash and equivalents	28.3	26.8	1.89	1.86	4.13	6.15	4.18	24.1	41.8	38.1
Receivables	19.6	19.8	45.5	32.4	27.6	35.3	44.3	41.7	30.1	30.8
Inventory	10.9	13.5	25.8	21.7	18.4	25.1	23.9	22.1	18.3	19.7
Other current assets	0.91	1.39	1.47	3.72	4.38	5.94	5.67	8.62	6.76	8.16
Total current assets	59.9	65	80.3	61.2	56.5	75.1	80.7	103	103	103
Property, plant and equipment	70.6	68.6	80.7	79.2	74.1	75.9	83.3	81.2	80.8	86.9
Lease right-of-use assets			0	4.48	2.75	5.58	5.11	3.8	2.11	14.5
Goodwill	2.4	2.4	21.5	17.4	17.4	17.4	17.4	17.4	17.4	17.4
Intangible assets	0.56	0.51	15.4	13.5	11.5	9.57	7.62	6.02	4.43	3.48
Other non-current assets	0	2.08	2.2	1.53	2.4	3.13	4.57	2.12	1.94	2.52
Total assets	133	139	201	179	166	187	199	213	210	228
Accounts payable	8.53	13.9	25.5	19.9	17	22.7	29.6	24	17.1	14.9
Accrued liabilities	5	3.52	5.15	5.52	8.31	7.53	9.1	10.5	7.59	4.99
Deferred revenue				3.7	1.32	6.26	1.4	5.2	2.29	5.02
Short-term debt	3	3	3.23	50.3	2.54	3.94	1.21	1.47	1.81	2.08
Total current liabilities	21.3	24.6	40.2	83.8	36	53.1	50.8	46.2	36.7	34.2
Long-term debt	6.75	3.75	55.2	0	25.2	21.3	23	21.5	19.7	17.6
Lease liabilities			0	3.12	1.67	4.02	3.52	1.83	1	13.1
Other non-current liabilities				3.12	2.56	4.61	3.52	3.76	1.62	1.94
Total liabilities	36.7	36.7	102	94.9	71.6	86.6	82.5	74.4	62.2	70
Total debt	9.75	3.75	37.8	0	25.2	21.3	23	21.5	19.7	17.6
Paid-in capital	30.1	31.5	33.2	34.8	36.1	38	40.3	43.3	45.8	47.5
Retained earnings	91.9	96.4	91.9	76.7	84.9	89.5	102	122	135	147
Treasury stock	-27.8	-28.2	-28.4	-28.5	-28.5	-28.6	-29.1	-31.8	-36.1	-39.9
Other comprehensive income	2.41	2.07	2.12	1.37	1.38	1.08	3.05	5.3	2.29	3.94
Shareholders' equity	96.8	103	98.9	84.4	93.9	100	116	139	147	158
Total equity	96.8	103	98.9	84.4	93.9	100	116	139	147	158
Total liabilities and equity	133	139	201	179	166	187	199	213	210	228
Shares outstanding	7.64	7.71	7.78	7.88	7.98	8.24	8.42	8.66	8.61	8.51

Cash flow statement

	FY2016	FY2016	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2023	FY2025
Net income	7.41	5.46	-4.78	-15.2	8.17	4.67	12.2	20.3	13.3	11.2
Depreciation and amortization	6.28	6.24	9.38	10.4	11.7	11.6	11.9	12.9	13.4	12.3
Stock-based compensation	1	1.33	1.74	1.56	1.36	1.89	2.33	2.92	2.5	1.79
Deferred income tax	0.43	-0.34	-1.71	-1.06	2.1	-0.37	-3.47	2.47	0.47	-0.83
Change in receivables	17.3	-0.3	-17.9	13	4.84	-8.95	-9	2.55	11.6	-0.71
Change in inventory	2.79	-2.55	-5.78	4.08	3.32	-6.77	1.26	1.81	3.72	-1.37
Change in payables	-4.69	5.35	7.82	-4.85	-3.14	5.35	6	-4.92	-8.11	-2.45
Cash from operations	26.1	6.91	-6.53	16.7	28.2	12.5	19	34.8	35.2	19.2
Capital expenditures	-2.86	-4.26	-5.8	-7.46	-3.68	-11.6	-16.6	-9.1	-11.5	-17.3
Cash from investing	-2.86	-4.26	-68.8	-7.46	-3.68	-11.4	-16.6	-9.1	-11.5	-17.3
Debt issued				0	30.2	0	25	0	0
Debt repaid			-10.1	-3.38	-38.7	-3.02	-25.9	-1.29	-1.55	-1.89
Stock issued	0	0
Share buybacks			-0.25	-0.1	-0.02	-0.1	0	0	-2.94	-3.17
Dividends paid	0	-0.79	-0.79	0	0
Cash from financing	-3.86	-4.16	50.4	-9.28	-22.2	0.88	-4.36	-5.82	-5.93	-5.66
Net change in cash	19.3	-1.51	-24.9	-0.04	2.28	2.02	-1.96	19.9	17.7	-3.75
Free cash flow	23.2	2.65	-12.3	9.24	24.5	0.98	2.39	25.7	23.6	1.92
Interest paid	0.29	0.25	2.26	3.87	3.85	1.84	1.68	1.23	1.07	1.02
Income taxes paid	1.88	2.41	1.03	1.28	0.57	5.07	6.65	5.25	2.16	3.67

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $23.21 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	18.2%	Gross profit / revenue.
Operating margin	3.6%	Operating income / revenue.
EBITDA margin	8.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.7%	Pre-tax income / revenue.
Net margin	2.9%	Net income / revenue.
FCF margin	-3.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.5%	Cash from operations / revenue.
Effective tax rate	22.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.2%	Net income / average total assets.
Return on invested capital (ROIC)	4.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	9.8%	Capital expenditures / revenue.
D&A / revenue	4.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-9.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-10.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-14.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-7.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-11.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-3.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-15.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-2.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	6.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-14.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-3.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	5.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-45.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	0.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-91.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-7.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-39.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	11.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.00x	Current assets / current liabilities.
Quick ratio	0.98x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.25x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	29.2%	Total liabilities / total assets.
Net debt	-$12.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.58x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	56.6x	Operating income / interest expense.
Working capital	$48.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	9.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$140.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.12x	Revenue / average total assets.
Fixed asset turnover	2.72x	Revenue / average property, plant and equipment.
Inventory turnover	7.62x	Cost of revenue / average inventory.
Days inventory	48 days	365 x average inventory / cost of revenue.
Receivables turnover	7.21x	Revenue / average receivables.
Days sales outstanding	51 days	365 x average receivables / revenue.
Days payables	42 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	57 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-113.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	149.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.86	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$29.21	Revenue / diluted weighted shares.
FCF per share	-$0.95	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.91	Cash from operations / diluted weighted shares.
Book value per share	$18.81	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.43	Tangible book value / shares outstanding.
Cash per share	$1.42	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$205.4M	Share price x shares outstanding.
Enterprise value	$193.3M	Market cap + total debt - cash - short-term investments.
P/E	28.0x	Market cap / net income. Only when net income is positive.
P/S	0.81x	Market cap / revenue.
P/B	1.28x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.46x	Market cap / tangible book value, when positive.
P/OCF	12.3x	Market cap / cash from operations, when positive.
EV/Sales	0.76x	Enterprise value / revenue.
EV/EBIT	21.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.28x	Enterprise value / EBITDA, when both are positive.
FCF yield	-4.0%	Free cash flow / market cap.
Earnings yield	3.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.6%	(Dividends paid + share buybacks) / market cap.

What was CORE MOLDING TECHNOLOGIES INC's revenue in fiscal 2025?

CORE MOLDING TECHNOLOGIES INC reported revenue of $273.8M for fiscal 2025, 9.5% lower than the year before.

Was CORE MOLDING TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $11.2M, a net margin of 4.1%.

How much free cash flow did CORE MOLDING TECHNOLOGIES INC generate in fiscal 2025?

Cash from operations of $19.2M minus capital expenditures of $17.3M left free cash flow of $1.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CORE MOLDING TECHNOLOGIES INC